Phase II study of prolonged oral etoposide in refractory ovarian cancer

J. J. KAVANAGH; D. TRESUKOSOL; GONZALEZ C. DE LEON; C. L. EDWARDS; R. S. FREEDMAN; M. HORD; E. HOWELL; R. LENZI; I. H. KRAKOFF; A. P. KUDELKA

doi:10.1046/j.1525-1438.1995.05050351.x

Article info

Original Articles

Phase II study of prolonged oral etoposide in refractory ovarian cancer

Authors

J. J. KAVANAGH The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA and *Chulalongkorn University Hospital, Bangkok, Thailand PubMed articles Google scholar articles
D. TRESUKOSOL The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA and *Chulalongkorn University Hospital, Bangkok, Thailand PubMed articles Google scholar articles
GONZALEZ C. DE LEON The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA and *Chulalongkorn University Hospital, Bangkok, Thailand PubMed articles Google scholar articles
C. L. EDWARDS The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA and *Chulalongkorn University Hospital, Bangkok, Thailand PubMed articles Google scholar articles
R. S. FREEDMAN The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA and *Chulalongkorn University Hospital, Bangkok, Thailand PubMed articles Google scholar articles
M. HORD The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA and *Chulalongkorn University Hospital, Bangkok, Thailand PubMed articles Google scholar articles
E. HOWELL The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA and *Chulalongkorn University Hospital, Bangkok, Thailand PubMed articles Google scholar articles
R. LENZI The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA and *Chulalongkorn University Hospital, Bangkok, Thailand PubMed articles Google scholar articles
I. H. KRAKOFF The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA and *Chulalongkorn University Hospital, Bangkok, Thailand PubMed articles Google scholar articles
A. P. KUDELKA The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA and *Chulalongkorn University Hospital, Bangkok, Thailand PubMed articles Google scholar articles

Address for correspondence: Dr A. P. Kudelka, MD Anderson Cancer Center, 1515 Holcombe Boulevard, Box 39, Houston, TX 77030, USA.

Citation

KAVANAGH JJ, TRESUKOSOL D, DE LEON GC, et al

Phase II study of prolonged oral etoposide in refractory ovarian cancer

International Journal of Gynecologic Cancer 1995;5:351-354.

Publication history

First published September 1, 1995.

Online issue publication

February 26, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

International Gynecologic Cancer Society

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password